Liberty review

What it is

Liberty (branded Liberty Health) is a nationwide online weight-loss and wellness service whose catalog runs compounded sermorelin injections, NAD⁺ injections, metformin, compounded semaglutide and tirzepatide injections, a low-dose microdosing line for both GLP-1s, and an ED product. You complete a quiz, a licensed provider reviews it, and prescribed medication ships to your door. It states availability in all 50 states with free discreet shipping, 24/7 support and FSA/HSA acceptance, with clinical oversight run through Physician Oversight Inc.

How it works

Quiz-led and fully asynchronous, built as a single-page application with a separate patient portal. The 503B claim is the substantive part of the model and deserves to be understood rather than nodded at: 503A pharmacies compound against individual patient prescriptions and are not required to follow CGMP, while 503B outsourcing facilities register with the FDA, must follow CGMP and are subject to FDA inspection. Choosing the stricter route is a real decision and Liberty makes it repeatedly across its own bundle. It then declines to name the facility, which converts a verifiable claim into an unverifiable one — you cannot look up an inspection history for a facility you have not been told the name of. The rest of the disclosure picture is thin too: limited public detail on the operating entity beyond the Liberty Health brand, no LegitScript seal, no named medical director, and a storefront that renders client-side, so its own product prices are effectively invisible to anyone reading the site from outside. Cancellation terms are not stated beyond the availability of monthly rather than three-month billing.

Pricing transparency

Liberty's catalog lists compounded sermorelin injections at $116 for a one-month supply and $122 for a three-month option, and NAD⁺ injections at $149 for one month and $399 for three. The $116 is the lowest sermorelin figure in this batch by a clear margin. Two cautions. The one-month and three-month sermorelin figures sit oddly close together, which is either a bundle we have read wrong or a catalog inconsistency, so confirm exactly what each covers before ordering. And because the storefront renders client-side, none of these prices sits on a static page you can screenshot and hold the company to — the figures are what its own catalog carries, and you should verify them at checkout. On the GLP-1 side, compounded semaglutide is a flat $199/mo, about $171/mo on a three-month supply, and tirzepatide a flat $299/mo; metformin is $49, which is a separate product and not, as has sometimes been reported, a microdosing price.

Branded vs compounded

Compounded; not FDA-approved. Prescription required only if a licensed provider finds it appropriate. Liberty states that its compounded medication comes from FDA-registered 503B outsourcing facilities — a stricter standard than 503A compounding, involving CGMP compliance and FDA inspection — but does not name the facility, and no compounded product, 503B or otherwise, is FDA-approved or reviewed for safety and efficacy as a finished drug. On the evidence: sermorelin is a GHRH analogue that stimulates your own pituitary to release growth hormone rather than supplying it exogenously, so the somatostatin feedback loop is preserved. The mechanism is real and well described; the long-term human outcome data behind the body-composition, sleep and recovery claims stays thin, which is the honest frame for a $116 monthly commitment. Injected NAD⁺ has no controlled human outcome trials at all — the single human intravenous study was a pharmacokinetic pilot finding infused NAD⁺ clears from plasma quickly — while the oral precursors NR and NMN reliably raise blood NAD⁺, which is a raised biomarker rather than a demonstrated clinical benefit. Individual results vary.

Pros and watch-outs

The evidence behind what Liberty prescribes

We grade the molecules, not the marketing. Here is what the human data actually shows for each thing on their menu.

• Sermorelin: a real GHRH drug, read against the anti-aging pitch

  An approved growth-hormone-releasing analog with a pediatric track record — and a longevity case built more on biomarkers than outcomes.

• NAD+ precursors (NR and NMN): what the human trials actually show

  They raise NAD+ and look safe short-term — but human evidence is surrogate-marker level, and no trial shows they extend healthspan.

How Liberty compares

A few alternatives worth a look, depending on what you’re optimizing for.

• KOKongo

  NAD⁺ injections at a published flat rate across all 50 states

  See Kongo →
• LTLttl

  Shoppers who want every commitment tier priced openly before they hand over anything

  See Lttl →
• LRLevelUp Rx

  NAD⁺ injections from a platform that names the pharmacies dispensing them

  See LevelUp Rx →